This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The Center for Protein Stucture and Function has made excellent progress in establishing the following Core facilities: 1) An NMR core facility with a new 700 MHz NMR with cryoprobe, a new 500 MHz NMR with cryoprobe, a totally rebuilt 500 MHz NMR, a rebuilt 300 MHz wide-bore solid-state NMR, and a 300 MHz NMR. 2) A modern protein X-ray crystallography laboratory with a Raxis4 area detector. 3) A mass spectrometry lab with a new Bruker Esquire ESI quadrupole ion trap spectrometer equipped with an electrospray ionization source, a new Bruker Reflex III MALDI time-of-flight spectrometer, and three Fourier transform mass spectrometers, including a 9.4 T FTMS. 4) Advanced computational resources with parallel processing computers. 5) A protein chemistry laboratory with an Applied Biosystems gas phase protein sequenator, an Applied Biosystems peptide synthesizer, and Beckman analytical and preparative ultracentrifuges. The Center is building upon these research capabilities by hiring five new faculty and acquiring new state-of-the-art instrumentation.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
Exploratory Grants (P20)
Project #
5P20RR015569-07
Application #
7381114
Study Section
Special Emphasis Panel (ZRR1-RI-8 (01))
Project Start
2006-05-01
Project End
2007-04-30
Budget Start
2006-05-01
Budget End
2007-04-30
Support Year
7
Fiscal Year
2006
Total Cost
$472,802
Indirect Cost
Name
University of Arkansas at Fayetteville
Department
Chemistry
Type
Schools of Arts and Sciences
DUNS #
191429745
City
Fayetteville
State
AR
Country
United States
Zip Code
72701
Davis, Julie Eberle; Alghanmi, Arwa; Gundampati, Ravi Kumar et al. (2018) Probing the role of proline -135 on the structure, stability, and cell proliferation activity of human acidic fibroblast growth factor. Arch Biochem Biophys 654:115-125
Kang, Seong W; Jayanthi, Srinivas; Nagarajan, Gurueswar et al. (2018) Identification of avian vasotocin receptor subtype-specific antagonists involved in the stress response of the chicken, Gallus gallus. J Biomol Struct Dyn :1-15
Jayanthi, Srinivas; Gundampati, Ravi Kumar; Kumar, Thallapuranam Krishnaswamy Suresh (2017) Simple and Efficient Purification of Recombinant Proteins Using the Heparin-Binding Affinity Tag. Curr Protoc Protein Sci 90:6.16.1-6.16.13
Prudovsky, Igor; Kacer, Doreen; Davis, Julie et al. (2016) Folding of Fibroblast Growth Factor 1 Is Critical for Its Nonclassical Release. Biochemistry 55:1159-67
Manoj, Kelath Murali; Parashar, Abhinav; Gade, Sudeep K et al. (2016) Functioning of Microsomal Cytochrome P450s: Murburn Concept Explains the Metabolism of Xenobiotics in Hepatocytes. Front Pharmacol 7:161
Yadav, N; Kumar, S; Marlowe, T et al. (2015) Oxidative phosphorylation-dependent regulation of cancer cell apoptosis in response to anticancer agents. Cell Death Dis 6:e1969
Stratford Jr, Robert; Vu, Christopher; Sakon, Joshua et al. (2014) Pharmacokinetics in rats of a long-acting human parathyroid hormone-collagen binding domain peptide construct. J Pharm Sci 103:768-75
Ponnapakkam, T; Katikaneni, R; Sakon, J et al. (2014) Treating osteoporosis by targeting parathyroid hormone to bone. Drug Discov Today 19:204-8
Katikaneni, Ranjitha; Ponnapakkam, Tulasi; Matsushita, Osamu et al. (2014) Treatment and prevention of chemotherapy-induced alopecia with PTH-CBD, a collagen-targeted parathyroid hormone analog, in a non-depilated mouse model. Anticancer Drugs 25:30-8
Katikaneni, Ranjitha; Ponnapakkam, Tulasi; Seymour, Andrew et al. (2014) Parathyroid hormone linked to a collagen binding domain promotes hair growth in a mouse model of chemotherapy-induced alopecia in a dose-dependent manner. Anticancer Drugs 25:819-25

Showing the most recent 10 out of 204 publications